From the Food and Drug Administration.
Nightingale
S L
SL
Office of Health Affairs, FDA, Rockville, MD 20857, USA.
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003195:Computer Communication Networks; D000077265:Donepezil; D017277:Drug Approval; D004346:Drug Information Services; D004348:Drug Labeling; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008327:Mammography; D008490:Medical Informatics; D010880:Piperidines / Q000627:therapeutic use*; D011643:Publishing; D014481:United States; D014486:United States Food and Drug Administration
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil